-
-
-
-
-
-
-
First Two Patients Treated in Pilot Clinical Study with Bone Biologics’ NB1 Bone Graft Device in Spine Fusion
-
-
-
-
-
-
-
Form S-1 Bone Biologics Corp
-
-
-
-
-
-
-
Bone Biologics Prices $5.0 Million Underwritten Public Offering
-
-
-
-
-
-
-
Bone Biologics Receives Human Research Ethics Committee Approval to Begin Pilot Clinical Trial with NB1 in Spinal Fusion Patients in Australia
-
-
-
-
-
-
-
Bone Biologics (BBLG) Prices 3.78M Share Offering at $1.35/sh
-
-
-
-
-
-
-
Bone Biologics (BBLG) Enters Supply Agreement with MTF Biologics for Demineralized Bone Matrix
-
-
-
-
-
-
-
Form S-1/A Bone Biologics Corp
-
66,826 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

